Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- N/A
ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE3
ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection
- Status
- COMPLETED
- Phase
- PHASE3
A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults
- Status
- COMPLETED
- Phase
- PHASE2
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients
- Status
- COMPLETED
- Phase
- N/A
Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults
- Status
- COMPLETED
- Phase
- PHASE3
Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)
- Status
- COMPLETED
- Phase
- PHASE2